Sunburn

L12_SUNBURN

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L55 Hospital discharge: ICD-9 — 6927A Cause of death: ICD-10 — L55 Cause of death: ICD-9 — 6927A 2 out of 7 registries used, show all original rules.	71
4. Check minimum number of events None	71
5. Include endpoints None	71
6. Filter based on genotype QC (FinnGen only)	71

Control definitions (FinnGen only)

Control exclude: L12_RADIATIONRELATEDSKIN

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L55-L59
Name in latin: Erythema solare

NAME	L12_SUNBURN
CONTROL_EXCLUDE	L12_RADIATIONRELATEDSKIN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L55
HD_ICD_9	6927A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L55
COD_ICD_9	6927A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sunburn based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	631	298	326
Only index persons	553	272	281
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	37.42	44.67	30.51
Only index persons	36.73	43.53	30.16

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	71	35	36
Unadjusted period prevalence (%)	0.01	0.01	0.02
Median age at first event (years)	43.10	43.74	42.47

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
65: Matched controls
650

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L55.9

ICD-10 Finland

Sunburn, unspecified

+∞

33.2

L55.0

ICD-10 Finland

Sunburn of first degree

+∞

19.8

L55.8

ICD-10 Finland

Other sunburn

+∞

10.7

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4.41

6.59

3.1

2.1

16.6

24.4

1.84

(3022948) Iron [Moles/volume] in Serum or Plasma

3.86

5.89

2.9

2.0

10.6

13.9

umol/l

1.51

(3004789) Transferrin [Mass/volume] in Serum or Plasma

3.59

4.99

3.0

2.0

2.3

2.4

g/l

0.31

(3021589) Normoblasts [#/volume] in Blood

239

2.85

4.46

9.3

7.9

0.0

e9/l

0.50

199

(3001604) Monocytes [#/volume] in Blood

263

2.77

4.15

8.1

5.9

0.6

e9/l

1.46

239

(3006315) Basophils [#/volume] in Blood

263

2.77

4.15

8.1

5.9

0.0

e9/l

0.43

240

(3026493) Urate [Moles/volume] in Serum or Plasma

144

2.71

3.89

3.1

2.7

361.3

8896.2

umol/l

1.06

121

(3019198) Lymphocytes [#/volume] in Blood

271

2.64

3.79

8.0

5.8

1.9

1.8

e9/l

0.52

251

(42870588) Differential panel, method unspecified - Blood

169

2.63

3.78

8.3

5.0

—

(3000991) Gas panel - Venous blood

3.81

3.66

7.0

5.5

—

(3013115) Eosinophils [#/volume] in Blood

274

2.59

3.66

8.4

5.9

0.2

e9/l

0.47

254

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3.25

3.51

6.2

3.7

1.0

mmol/l

0.29

(3012544) pH of Venous blood

3.41

3.14

6.4

2.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

8.06

3.12

1.3

1.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

326

2.46

3.11

11.1

10.3

4.8

4.1

e9/l

1.09

295

(3028707) Methadone [Presence] in Urine by Screen method

7.15

2.93

7.0

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

208

2.22

2.71

7.8

5.0

1.2

mmol/l

0.17

195

(3023368) Bacteria identified in Blood by Culture

135

2.31

2.67

5.7

3.8

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

5.05

2.67

11.6

7.2

24.8

25.2

mmol/l

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2.53

2.62

2.8

1.1

0.8

e6/l

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

7.57

2.59

2.2

1.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

428

2.46

2.50

9.2

7.6

72.7

77.8

u/l

0.77

403

(3037756) Immunofixation for Serum or Plasma

6.62

2.41

1.2

1.1

—

(3002032) Base excess in Venous blood by calculation

2.99

2.40

6.9

2.6

2.2

2.5

mmol/l

0.11

(1001926) Buprenorphine [Presence] in Urine by Screen method

4.19

2.31

6.1

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2.38

2.24

2.9

2.4

e6/l

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

5.28

2.10

1.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.44

2.04

1.7

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.37

2.04

3.1

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

3.99

1.98

1.2

1.1

—

(3030467) Casts [#/volume] in Urine by Automated count

136

2.02

1.89

4.7

2.9

0.1

0.4

e6/l

1.00

107

(3022145) Colonoscopy Study observation

2.34

1.79

1.2

1.3

—

(4094501)

4.05

1.74

1.2

1.1

—

(3012516) Albumin [Mass/volume] in Urine

132

1.97

1.72

4.0

3.0

3318.4

542.8

mg/l

0.37

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

531

2.32

1.72

22.8

11.4

81.3

87.2

ml/min/173m2

1.11

436

(3020682) Albumin/Creatinine [Ratio] in Urine

141

1.93

1.69

5.2

3.5

5.9

10.6

mg/mmol

0.45

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

175

1.88

1.68

4.4

2.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2.21

1.68

1.9

1.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

364

1.86

1.64

5.8

4.0

—

(3011288) Drugs identified in Urine by Screen method

3.76

1.64

11.4

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

185

1.85

1.64

2.3

1.7

89.9

98.2

pmol/l

0.27

(3004588) Protein electrophoresis panel - Serum or Plasma

2.87

1.62

1.6

1.5

—

(3016879) Cocaine [Presence] in Urine

2.76

1.56

6.1

1.3

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.27

1.47

2.5

1.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.88

1.47

5.5

3.1

1.3

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

3.28

1.46

3.4

1.6

—

(3018095) Leukocytes [#/volume] in Urine

174

1.78

1.43

5.5

3.6

125.1

73.9

e6/l

0.18

128

(3000764) Benzodiazepines [Presence] in Urine

2.56

1.43

6.1

1.2

—

(3027008) Opiates [Presence] in Urine

2.56

1.43

6.1

1.2

—

(3028300) Cannabinoids [Presence] in Urine

2.56

1.43

6.3

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

2.37

1.43

2.9

4.4

—

0.8

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1.94

1.43

1.8

1.3

0.9

13.7

u/ml

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3.08

1.38

1.2

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

125

1.84

1.37

1.8

1.6

1.3

0.8

mg/l

0.37

100

(3027945) Reticulocytes/100 erythrocytes in Blood

2.18

1.36

2.3

3.1

1.6

1.7

0.12

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

101

1.90

1.35

6.2

2.8

205.3

189.1

ng/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

581

2.40

1.33

27.2

12.2

27.6

21.7

mg/l

0.57

449

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

409

1.75

1.31

3.3

4.0

15.0

14.8

pmol/l

0.23

382

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.14

1.30

3.2

1.6

—

(3019225) pH of Specimen

2.24

1.23

6.1

3.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.18

1.20

1.4

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

1.19

0.0

1.5

—

(3000494) Fungus identified in Specimen by Culture

1.93

1.16

1.3

—

(3015736) pH of Urine

202

1.64

1.14

3.9

3.5

—

(3035350) Ketones [Presence] in Urine by Test strip

259

1.60

1.11

4.1

3.7

0.0

estimate

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

116

1.74

1.10

2.4

2.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

133

1.70

1.10

3.7

6.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.17

1.06

11.3

6.7

—

(3002582) Erythrocytes [#/volume] in Urine

153

1.63

1.02

4.9

3.0

81.2

40.9

e6/l

0.24

122

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

102

1.73

1.01

1.8

1.3

37.5

22.4

iu/ml

—

(3044640) Blood type and Crossmatch panel - Blood

172

1.60

0.99

2.4

2.1

—

(40758558) Short blood count panel - Blood

146

1.62

0.97

7.7

6.9

—

(3025159) Blasts/100 leukocytes in Blood

2.02

0.92

2.3

4.2

—

0.0

—

(3027944) Amphetamines [Presence] in Urine

2.16

0.92

7.0

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

261

1.49

0.86

5.9

5.0

0.0

estimate

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.69

0.86

1.5

1.7

—

(40761511) CBC panel - Blood by Automated count

614

2.06

0.86

22.4

11.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.79

0.84

2.3

1.4

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

108

1.62

0.82

3.9

3.8

—

(3009261) Glucose [Presence] in Urine by Test strip

265

1.46

0.78

4.4

3.7

0.0

estimate

—

(36304419) Bacteria [Presence] in Urine

136

1.54

0.77

5.5

2.8

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

194

1.45

0.69

3.9

3.8

18.9

54.1

ng/l

0.90

116

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.84

0.67

1.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

549

1.60

0.67

28.1

12.4

41.6

41.0

0.39

426

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.65

0.67

3.0

1.8

—

(3044889) 12 lead EKG panel

381

1.41

0.65

3.6

3.5

—

(3003694) ABO and Rh group [Type] in Blood

169

0.65

0.61

1.5

1.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

343

1.38

0.61

5.8

4.2

—

621.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.61

0.0

1.5

—

(3032080) INR in Blood by Coagulation assay

208

1.39

0.60

21.5

6.3

1.2

1.1

inr

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

126

1.46

0.59

2.2

1.8

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

512

1.44

0.55

5.0

4.5

1.9

mu/l

0.07

472

(3002256) Pathology report gross observation

1.46

0.54

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.55

0.53

2.2

1.5

—

(3013512) EKG study

129

1.42

0.52

6.8

3.5

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

176

1.36

0.50

3.4

2.9

2.3

2.4

mmol/l

0.30

154

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.58

0.50

3.0

8.4

—

(3029937) Albumin [Presence] in Urine by Test strip

131

1.39

0.48

5.6

3.9

0.0

estimate

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

609

1.52

0.43

27.5

14.1

79.9

75.1

umol/l

0.93

609

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.60

0.43

2.8

1.1

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1.60

0.43

1.4

2.4

0.1

e6/l

—

(40768804) Tissue Pathology biopsy report

218

1.30

0.43

2.3

1.8

—

(40761535) Cells panel - Urine sediment

1.55

0.42

4.0

4.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.41

0.0

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

0.00

0.41

0.0

1.9

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.41

0.0

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.41

0.0

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.41

0.0

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.41

0.0

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.41

0.0

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.41

0.0

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.41

0.0

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.44

0.41

1.7

1.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

0.00

0.39

0.0

2.3

—

4.1

—

(4035726)

1.51

0.37

1.3

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.40

0.36

3.0

1.9

—

(3026008) Bacteria identified in Urine by Culture

157

1.29

0.34

3.9

2.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.33

0.34

2.0

3.4

—

(4010399)

1.38

0.24

1.2

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1.30

0.23

1.4

1.9

2.0

5.8

ug/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

402

1.18

0.22

3.7

3.3

—

(3003181) Sodium [Moles/volume] in Urine

0.00

0.21

0.0

1.5

—

71.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.21

0.0

3.2

—

19.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

156

1.21

0.21

4.4

3.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

62.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

205

1.18

0.20

5.1

3.7

—

(3042936) Bacteria identified in Isolate by Culture

0.78

0.16

3.0

2.0

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

576

0.87

0.12

5.6

4.4

2.7

2.8

mmol/l

0.38

536

(36660697) Celiac disease serology panel - Serum

1.09

0.10

1.2

—

(1761868) Lipid panel - Serum or Plasma

225

0.91

0.09

3.4

2.6

—

(3000492) Spirometry study

1.12

0.08

1.3

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.81

0.08

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

269

1.07

0.05

3.5

3.9

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

114

1.06

0.01

1.6

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

539

1.01

0.00

5.4

4.0

6.0

5.9

mmol/l

0.13

498

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.0

2.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

3.1

—

14.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

5.5

—

26.5

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.0

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

4.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

0.0

2.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

0.0

1.6

—

7.7

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

0.0

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

0.00

0.0

1.2

—

925.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.0

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

0.0

1.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

0.0

2.6

—

13.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

0.0

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

0.0

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.0

2.4

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.0

1.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

0.00

0.0

1.2

—

20.7

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

0.00

0.0

1.3

—

(40768797) Stomach Pathology biopsy report

1.00

0.00

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.00

0.0

1.1

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.0

4.9

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

0.0

4.8

—

(3019977) pH of Arterial blood

0.00

0.0

4.2

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

20.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.0

1.7

—

5.3

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

0.0

2.4

—

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.99

0.00

1.3

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.0

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.0

2.9

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

0.0

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_SUNBURN and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_SUNBURN.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_SUNBURN – Sunburn

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sunburn

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints